SOPHiA GENETICS (NASDAQ:SOPH) Shares Up 8.7% - Time to Buy?

SOPHiA GENETICS SA (NASDAQ:SOPH - Get Free Report)'s share price traded up 8.7% during trading on Monday . The company traded as high as $3.27 and last traded at $3.25. 159,559 shares were traded during mid-day trading, an increase of 170% from the average session volume of 59,113 shares. The stock had previously closed at $2.99.

SOPHiA GENETICS Stock Down 6.9%

The company has a debt-to-equity ratio of 0.16, a current ratio of 3.11 and a quick ratio of 2.94. The firm has a market cap of $232.74 million, a price-to-earnings ratio of -3.49 and a beta of 1.00. The firm has a 50 day moving average price of $3.05 and a 200-day moving average price of $3.23.

SOPHiA GENETICS (NASDAQ:SOPH - Get Free Report) last issued its quarterly earnings results on Tuesday, May 6th. The company reported ($0.26) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.21) by ($0.05). SOPHiA GENETICS had a negative net margin of 98.51% and a negative return on equity of 63.47%. The firm had revenue of $17.78 million for the quarter, compared to analyst estimates of $16.76 million. As a group, equities analysts predict that SOPHiA GENETICS SA will post -0.96 EPS for the current fiscal year.

Institutional Investors Weigh In On SOPHiA GENETICS

A number of institutional investors and hedge funds have recently added to or reduced their stakes in SOPH. Federated Hermes Inc. increased its holdings in SOPHiA GENETICS by 40.5% in the fourth quarter. Federated Hermes Inc. now owns 100,000 shares of the company's stock valued at $312,000 after purchasing an additional 28,819 shares during the last quarter. Dimensional Fund Advisors LP increased its holdings in shares of SOPHiA GENETICS by 23.5% in the fourth quarter. Dimensional Fund Advisors LP now owns 21,619 shares of the company's stock worth $68,000 after acquiring an additional 4,115 shares in the last quarter. Millennium Management LLC increased its holdings in shares of SOPHiA GENETICS by 6.5% in the fourth quarter. Millennium Management LLC now owns 698,634 shares of the company's stock worth $2,180,000 after acquiring an additional 42,689 shares in the last quarter. Silverberg Bernstein Capital Management LLC increased its holdings in shares of SOPHiA GENETICS by 54.4% in the first quarter. Silverberg Bernstein Capital Management LLC now owns 34,675 shares of the company's stock worth $115,000 after acquiring an additional 12,211 shares in the last quarter. Finally, Bank Pictet & Cie Europe AG increased its holdings in shares of SOPHiA GENETICS by 14.4% in the first quarter. Bank Pictet & Cie Europe AG now owns 255,200 shares of the company's stock worth $847,000 after acquiring an additional 32,200 shares in the last quarter. Institutional investors own 31.59% of the company's stock.

SOPHiA GENETICS Company Profile

SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. The company offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switzerland, France, Italy, rest of Europe, North America, the United States, Latin America, and the Asia-pacific.